InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: investingarc post# 40754

Monday, 01/23/2017 1:39:26 PM

Monday, January 23, 2017 1:39:26 PM

Post# of 203913
I believe that test listed on clinicaltrails.gov is to satisfy requirements to sell in US MMJ States. The March deadlines posted below are for separate Israel tests, I think, which I believe will allow for sales to start in EU.

Psoriasis (Skin Disease)
• Pharma-grade ‘challenge tests’ successfully completed
05/2016
• Safety study at Sheba, Tel Hashomer under approved
IRB (Helsinki) protocol. To be completed 3/2017
• In-vitro psoriasis efficacy study of the topical crème to
be completed by 3/2017
• IP owned by OWCP
• EXPECTED MARKET READINESS : Q2/2017